These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A history of biopharmaceutics in the Food and Drug Administration 1968-1993. Skelly JP AAPS J; 2010 Mar; 12(1):44-50. PubMed ID: 19936940 [TBL] [Abstract][Full Text] [Related]
4. Generic equivalence and non-equivalence of drugs. Smith RN Lancet; 1972 Sep; 2(7776):528-30. PubMed ID: 4115582 [No Abstract] [Full Text] [Related]
5. Mental health and the elderly: new biopharmaceutic considerations. Cabana BE Health Aff (Millwood); 1983; 2(3):33-8. PubMed ID: 6654313 [No Abstract] [Full Text] [Related]
7. Drug bioequivalence. Recommendations from the Drug Bioequivalence Study Panel to the Office of Technology Assessment, Congress of the United States. J Pharmacokinet Biopharm; 1974 Oct; 2(5):433-66. PubMed ID: 4452945 [No Abstract] [Full Text] [Related]
8. Doctors are pivotal to prescription struggle. Chapman S Leg Aspects Med Pract; 1979 Mar; 7(3):42-4. PubMed ID: 423688 [No Abstract] [Full Text] [Related]
9. Bioavailability and bioequivalence: an FDA regulatory overview. Chen ML; Shah V; Patnaik R; Adams W; Hussain A; Conner D; Mehta M; Malinowski H; Lazor J; Huang SM; Hare D; Lesko L; Sporn D; Williams R Pharm Res; 2001 Dec; 18(12):1645-50. PubMed ID: 11785681 [TBL] [Abstract][Full Text] [Related]
10. [Bioavailability of drug products and bioequivalence requirements (author's transl)]. Jaminet F J Pharm Belg; 1978; 33(3):141-56. PubMed ID: 682101 [No Abstract] [Full Text] [Related]
11. Importance of biopharmaceutics and pharmacokinetics in clinical medicine. Cabana BE Arzneimittelforschung; 1976; 26(1A):151-8. PubMed ID: 947194 [TBL] [Abstract][Full Text] [Related]
13. Classification of torasemide based on the Biopharmaceutics Classification System and evaluation of the FDA biowaiver provision for generic products of CLASS I drugs. Khan MZ; Rausl D; Radosević S; Filić D; Danilovski A; Dumić M; Knezević Z J Pharm Pharmacol; 2006 Nov; 58(11):1475-82. PubMed ID: 17132210 [TBL] [Abstract][Full Text] [Related]
14. Impact of the US FDA "Biopharmaceutics Classification System" (BCS) Guidance on Global Drug Development. Mehta MU; Uppoor RS; Conner DP; Seo P; Vaidyanathan J; Volpe DA; Stier E; Chilukuri D; Dorantes A; Ghosh T; Mandula H; Raines K; Dhanormchitphong P; Woodcock J; Yu LX Mol Pharm; 2017 Dec; 14(12):4334-4338. PubMed ID: 29076742 [TBL] [Abstract][Full Text] [Related]
16. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration. Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300 [TBL] [Abstract][Full Text] [Related]